Amgen to close Bothell, Seattle facilities

BOTHELL — Despite “robust growth,” Amgen, one of the world’s biggest pharmaceutical companies, is shutting down operations in Bothell and Seattle, which means the loss of several hundred jobs in Washington.

The company also plans to pull out of Colorado and reduce its headquarters workforce, while expanding in biotechnology hubs in San Francisco and Cambridge, Massachusetts. The moves are expected to trim operating costs, Amgen CEO Robert Bradway told investors and stock analysts on Tuesday.

In all, the company plans to cut 2,400 to 2,900 jobs — about 12 to 15 percent of its global workforce — by the end of 2015.

Bradway praised workers at the locations to be closed, saying they “have made enormous contributions to advancing biotechnology over the years and the surrounding communities have been very supportive, so it is with great reluctance that we acknowledge the need to exit.”

Amgen, which is based in Thousand Oaks, California, is talking with “third-parties about potential use of the facilities,” he said.

The changes will shrink Amgen’s physical presence by 23 percent, and reduce operating costs by about $700 million by 2016 as compared to 2013. The savings will be used to support new product launches, according to a news release from the company.

Amgen is also considering other steps to increase efficiency and trim costs, according to the release.

The company did not immediately respond to requests for comment.

The Bothell facility has fewer than 100 workers, according to news reports.

The company has about 660 research staff in Washington and 200 in Colorado, according to FierceBiotech, a news website that covers the biotechnology industry.

Despite the closures, Amgen’s revenue increased 11 percent in the second quarter of the year, as did its earnings per share, which saw a 25 percent jump to $2.37.

“From a position of strength, we have announced today restructuring initiatives that will allow us to reallocate resources to invest in our upcoming launches and drive growth,” Bradway said in the release.

Dan Catchpole: 425-339-3454; dcatchpole@heraldnet.com; Twitter: @dcatchpole.

More in Herald Business Journal

Health-care consumers need to take the lead, so get smart

David Russian, CEO of Western Washington Medical Group, writes our third essay about fixing health care.

Robots on Wall Street: Slow-footed regulators lose ground

Watchdogs have to figure out how to check computers running lightening-fast algorithms.

More business, more competition for Everett kidney dialysis center

Nonprofit Puget Sound Kidney Centers sees large for-profit competitors enter state market.

Molina Medical holds fall carnival for families in Everett

Molina Medical is hosting a free event for families in the Everett… Continue reading

Leadership Snohomish County celebrates 20 years of service

Leadership Snohomish County is celebrating its 20th anniversary. The organization was launched… Continue reading

Snohomish, Monroe manufacturers honored for innovation, excellence

Two Snohomish County companies have been honored with Manufacturing Excellence awards at… Continue reading

Remodeled home tours planned this weekend

This weekend, Edmonds-based Chermak Construction will participate in the 2017 Remodeled Homes… Continue reading

Barron Heating to celebrate anniversary at Marysville showroom

Barron Heating and Air Conditioning is celebrating its 45th anniversary from 10… Continue reading

US budget deficit hits $666B, an $80B spike for the year

The deficit issue has largely fallen in prominence in Washington in recent years.

Most Read